Carlsmed, Inc. Common Stock CARL
$17.12
-1.04%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $22.00
- Implied Upside
- +28.5%
- Price Target Range
- $17.00 – $26.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-11 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $20 → $23 |
| 2026-11-11 | NeedhamDavid Saxon |
Maintains | Buy | $17 → $22 |
| 2026-11-11 | BTIGRyan Zimmerman |
Maintains | Buy | $24 → $26 |
| 2026-10-12 | BTIGRyan Zimmerman |
Maintains | Buy | $23 → $24 |
| 2026-09-28 | BTIGRyan Zimmerman |
Reiterates | Buy | $23 |
| 2026-08-06 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $18 → $20 |
| 2026-07-01 | NeedhamDavid Saxon |
Initiates coverage on | Buy | $17 |
| 2026-05-06 | BTIGRyan Zimmerman |
Reiterates | Buy | $23 |
| 2026-04-15 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $20 → $18 |
| 2026-04-09 | Goldman SachsDavid Roman |
Maintains | Buy | $19 → $17 |
| 2025-12-15 | BTIGRyan Zimmerman |
Reiterates | Buy | $24 |
| 2025-11-07 | Truist SecuritiesRichard Newitter |
Reiterates | Buy | $18 → $20 |
| 2025-11-07 | BTIGRyan Zimmerman |
Maintains | Buy | $21 → $24 |
| 2025-08-18 | Truist SecuritiesRichard Newitter |
Initiates coverage on | Buy | $18 |
| 2025-08-18 | Goldman SachsDavid Roman |
Initiates coverage on | Buy | $19 |
| 2025-08-18 | Piper SandlerMatt O'Brien |
Initiates coverage on | Overweight | $18 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $17.12
- Market Cap
- $474.09 million
- 52-Week Range
- $8.50 – $19.15
- Average Volume
- 117K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.